COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists Adam Halberstadt and John McCorvy join Jason Wallach to develop new psychedelic compounds at the virtual Discovery Center London, UK – 9 February 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based…


Previous articleNew Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate
Next articleFeb 10: $SPOR +40.91%, $PSYC +35.42%, $MCUR +23.33%